RE: Company presentation Marc24 Oct 2022 11:00
From a consumer point of view, it looks good on the presentation. From an investor point of view, I am not so sure. Geremy's ultimate aim will be build up enough strength in the business to sell it on. That could be years away. I believe when the offer comes in for the business though it will be significant.
However, there were some real positives in there. Subscriptions, talking to insurance companies and not needing cash from anyone to progress further. Like the sound of all of that.
One drawback to the plan is the fact researchers are calling on five million UK adults to take part in one of the biggest studies in the world. Part of the study is to have blood tests for blood sugar levels, cholesterol and genetic testing. This is being funded by government money, industry and charities. If we are in on this then that great, if not, then a large section of the market has already been accessed for these tests.